{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T11:23:57Z","timestamp":1768908237357,"version":"3.49.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T00:00:00Z","timestamp":1548115200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Microbiol Immunol"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s00430-019-00577-x","type":"journal-article","created":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T22:58:24Z","timestamp":1548284304000},"page":"185-195","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Development of a novel multiepitope chimeric vaccine against anthrax"],"prefix":"10.1007","volume":"208","author":[{"given":"Somya","family":"Aggarwal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vikas Kumar","family":"Somani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonal","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajni","family":"Garg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rakesh","family":"Bhatnagar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,1,22]]},"reference":[{"issue":"5","key":"577_CR1","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/modpathol.3800087","volume":"17","author":"LW Lamps","year":"2004","unstructured":"Lamps LW, Havens JM, Sjostedt A, Page DL, Scott MA (2004) Histologic and molecular diagnosis of tularemia: a potential bioterrorism agent endemic to North America. Mod Pathol 17(5):489","journal-title":"Mod Pathol"},{"issue":"3","key":"577_CR2","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1080\/08998280.2005.11928074","volume":"18","author":"S Riedel","year":"2005","unstructured":"Riedel S (2005) Anthrax: a continuing concern in the era of bioterrorism. Proc Baylor Univ Med Center. 18(3):234","journal-title":"Proc Baylor Univ Med Center"},{"key":"577_CR3","doi-asserted-by":"publisher","first-page":"177","DOI":"10.2147\/RMHP.S56047","volume":"7","author":"O Grundmann","year":"2014","unstructured":"Grundmann O (2014) The current state of bioterrorist attack surveillance and preparedness in the US. Risk Manage Healthcare Pol 7:177","journal-title":"Risk Manage Healthcare Pol"},{"key":"577_CR4","doi-asserted-by":"publisher","first-page":"141","DOI":"10.4172\/2157-2526.1000141","volume":"7","author":"S Cogliati","year":"2016","unstructured":"Cogliati S, Costa J, Ayala F, Donato V, Grau R (2016) Bacterial spores and its relatives as agents of mass destruction. J Bioterror Biodef 7:141","journal-title":"J Bioterror Biodef"},{"issue":"6","key":"577_CR5","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.mam.2009.08.006","volume":"30","author":"RJ Cybulski Jr","year":"2009","unstructured":"Cybulski RJ Jr, Sanz P, O\u2019Brien AD (2009) Anthrax vaccination strategies. Mol Asp Med 30(6):490\u2013502","journal-title":"Mol Asp Med"},{"issue":"3","key":"577_CR6","doi-asserted-by":"publisher","first-page":"148","DOI":"10.2174\/187220811797579097","volume":"5","author":"M Kaur","year":"2011","unstructured":"Kaur M, Bhatnagar R (2011) Recent progress in the development of anthrax vaccines. Recent Patents Biotechnol 5(3):148\u2013159","journal-title":"Recent Patents Biotechnol"},{"key":"577_CR7","doi-asserted-by":"publisher","first-page":"D8","DOI":"10.1016\/j.vaccine.2009.08.055","volume":"27","author":"S Lu","year":"2009","unstructured":"Lu S, Wang S (2009) Technical transformation of biodefense vaccines. Vaccine 27:D8\u2013D15","journal-title":"Vaccine"},{"issue":"9","key":"577_CR8","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.4161\/hv.25337","volume":"9","author":"TJ Merkel","year":"2013","unstructured":"Merkel TJ, Perera P-Y, Lee GM, Verma A, Hiroi T, Yokote H et al (2013) Protective-antigen (PA) based anthrax vaccines confer protection against inhalation anthrax by precluding the establishment of a systemic infection. Hum Vaccines Immunother 9(9):1841\u20131848","journal-title":"Hum Vaccines Immunother"},{"issue":"10","key":"577_CR9","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1016\/j.molimm.2008.12.031","volume":"46","author":"M Kaur","year":"2009","unstructured":"Kaur M, Chug H, Singh H, Chandra S, Mishra M, Sharma M et al (2009) Identification and characterization of immunodominant B-cell epitope of the C-terminus of protective antigen of Bacillus anthracis. Mol Immunol 46(10):2107\u20132115","journal-title":"Mol Immunol"},{"issue":"6619","key":"577_CR10","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1038\/385833a0","volume":"385","author":"C Petosa","year":"1997","unstructured":"Petosa C, Collier RJ, Klimpel KR, Leppla SH, Liddington RC (1997) Crystal structure of the anthrax toxin protective antigen. Nature 385(6619):833","journal-title":"Nature"},{"issue":"11","key":"577_CR11","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1002\/pro.238","volume":"18","author":"AS Williams","year":"2009","unstructured":"Williams AS, Lovell S, Anbanandam A, El-Chami R, Bann JG (2009) Domain 4 of the anthrax protective antigen maintains structure and binding to the host receptor CMG2 at low pH. Protein Sci 18(11):2277\u20132286","journal-title":"Protein Sci"},{"issue":"3","key":"577_CR12","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1128\/IAI.70.3.1653-1656.2002","volume":"70","author":"HC Flick-Smith","year":"2002","unstructured":"Flick-Smith HC, Walker NJ, Gibson P, Bullifent H, Hayward S, Miller J et al (2002) A recombinant carboxy-terminal domain of the protective antigen of Bacillus anthracis protects mice against anthrax infection. Infect Immun 70(3):1653\u20131656","journal-title":"Infect Immun"},{"issue":"7","key":"577_CR13","doi-asserted-by":"publisher","first-page":"4509","DOI":"10.1128\/IAI.69.7.4509-4515.2001","volume":"69","author":"BM Price","year":"2001","unstructured":"Price BM, Liner AL, Park S, Leppla SH, Mateczun A, Galloway DR (2001) Protection against anthrax lethal toxin challenge by genetic immunization with a plasmid encoding the lethal factor protein. Infect Immun 69(7):4509\u20134515","journal-title":"Infect Immun"},{"issue":"15\u201316","key":"577_CR14","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1016\/j.molimm.2011.05.024","volume":"48","author":"P Kulshreshtha","year":"2011","unstructured":"Kulshreshtha P, Bhatnagar R (2011) Inhibition of anthrax toxins with a bispecific monoclonal antibody that cross reacts with edema factor as well as lethal factor of Bacillus anthracis. Mol Immunol 48(15\u201316):1958\u20131965","journal-title":"Mol Immunol"},{"issue":"4","key":"577_CR15","doi-asserted-by":"publisher","first-page":"3006","DOI":"10.1074\/jbc.M109997200","volume":"277","author":"DB Lacy","year":"2002","unstructured":"Lacy DB, Mourez M, Fouassier A, Collier RJ (2002) Mapping the anthrax protective antigen binding site on the lethal and edema factors. J Biol Chem 277(4):3006\u20133010","journal-title":"J Biol Chem"},{"issue":"11","key":"577_CR16","doi-asserted-by":"publisher","first-page":"4714","DOI":"10.1128\/IAI.00749-09","volume":"77","author":"ML Nguyen","year":"2009","unstructured":"Nguyen ML, Terzyan S, Ballard JD, James JA, Farris AD (2009) The major neutralizing antibody responses to recombinant anthrax lethal and edema factors are directed to non-cross-reactive epitopes. Infect Immun 77(11):4714\u20134723","journal-title":"Infect Immun"},{"key":"577_CR17","doi-asserted-by":"publisher","DOI":"10.1385\/1592593992","volume-title":"Vaccine protocols","author":"A Robinson","year":"2003","unstructured":"Robinson A, Farrar GH, Wiblin CN (2003) Vaccine protocols. Springer, New York"},{"issue":"2","key":"577_CR18","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.molimm.2015.09.011","volume":"68","author":"D Singh","year":"2015","unstructured":"Singh D, Somani VK, Aggarwal S, Bhatnagar R (2015) PLGA (85: 15) nanoparticle based delivery of rL7\/L12 ribosomal protein in mice protects against Brucella abortus 544 infection: a promising alternate to traditional adjuvants. Mol Immunol 68(2):272\u2013279","journal-title":"Mol Immunol"},{"key":"577_CR19","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3389\/fmicb.2016.00169","volume":"7","author":"VK Somani","year":"2016","unstructured":"Somani VK, Aggarwal S, Singh D, Prasad T, Bhatnagar R (2016) Identification of novel raft marker protein, FlotP in Bacillus anthracis. Front Microbiol 7:169","journal-title":"Front Microbiol"},{"key":"577_CR20","doi-asserted-by":"crossref","unstructured":"Aggarwal S, Somani VK, Gupta V, Kaur J, Singh D, Grover A et al. Functional characterization of PhoPR two component system and its implication in regulating phosphate homeostasis in Bacillus anthracis. Biochimica et Biophysica Acta (BBA)-general subjects. 2017;1861(1):2956\u20132970","DOI":"10.1016\/j.bbagen.2016.09.022"},{"issue":"11","key":"577_CR21","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1128\/CVI.00324-12","volume":"19","author":"CP Quinn","year":"2012","unstructured":"Quinn CP, Sabourin CL, Niemuth NA, Li H, Semenova VA, Rudge TL et al (2012) A three-dose intramuscular injection schedule of anthrax vaccine adsorbed generates sustained humoral and cellular immune responses to protective antigen and provides long-term protection against inhalation anthrax in rhesus macaques. Clin Vaccine Immunol 19(11):1730\u20131745","journal-title":"Clin Vaccine Immunol"},{"issue":"4","key":"577_CR22","doi-asserted-by":"publisher","first-page":"e61885","DOI":"10.1371\/journal.pone.0061885","volume":"8","author":"M Manish","year":"2013","unstructured":"Manish M, Rahi A, Kaur M, Bhatnagar R, Singh S (2013) A single-dose PLGA encapsulated protective antigen domain 4 nanoformulation protects mice against Bacillus anthracis spore challenge. PLoS One 8(4):e61885","journal-title":"PLoS One"},{"issue":"6","key":"577_CR23","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.biologicals.2009.08.017","volume":"37","author":"WH Organizaion","year":"2009","unstructured":"Organizaion WH (2009) Guidelines on stability evaluation of vaccines. Biologicals 37(6):424\u2013434","journal-title":"Biologicals"},{"key":"577_CR24","doi-asserted-by":"publisher","first-page":"D28","DOI":"10.1016\/j.vaccine.2009.08.102","volume":"27","author":"AM Friedlander","year":"2009","unstructured":"Friedlander AM, Little SF (2009) Advances in the development of next-generation anthrax vaccines. Vaccine 27:D28\u2013D32","journal-title":"Vaccine"},{"issue":"8","key":"577_CR25","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1586\/14760584.2013.814860","volume":"12","author":"M Kaur","year":"2013","unstructured":"Kaur M, Singh S, Bhatnagar R (2013) Anthrax vaccines: present status and future prospects. Expert Rev vaccines 12(8):955\u2013970","journal-title":"Expert Rev vaccines"},{"issue":"7","key":"577_CR26","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1128\/IAI.56.7.1807-1813.1988","volume":"56","author":"SF Little","year":"1988","unstructured":"Little SF, Leppla SH, Cora E (1988) Production and characterization of monoclonal antibodies to the protective antigen component of Bacillus anthracis toxin. Infect Immun 56(7):1807\u20131813","journal-title":"Infect Immun"},{"issue":"1\u20133","key":"577_CR27","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.molimm.2010.08.001","volume":"48","author":"K Sinha","year":"2010","unstructured":"Sinha K, Bhatnagar R (2010) GroEL provides protection against Bacillus anthracis infection in BALB\/c mice. Mol Immunol 48(1\u20133):264\u2013271","journal-title":"Mol Immunol"},{"issue":"6","key":"577_CR28","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.ijmm.2015.06.001","volume":"305","author":"S Aggarwal","year":"2015","unstructured":"Aggarwal S, Somani VK, Bhatnagar R (2015) Phosphate starvation enhances the pathogenesis of Bacillus anthracis. Int J Med Microbiol 305(6):523\u2013531","journal-title":"Int J Med Microbiol"},{"issue":"2","key":"577_CR29","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1046\/j.1365-2672.1999.00897.x","volume":"87","author":"M Pitt","year":"1999","unstructured":"Pitt M, Little S, Ivins B, Fellows P, Boles J, Barth J et al (1999) In vitro correlate of immunity in an animal model of inhalational anthrax. J Appl Microbiol 87(2):304-","journal-title":"J Appl Microbiol"},{"issue":"41","key":"577_CR30","doi-asserted-by":"publisher","first-page":"6740","DOI":"10.1016\/j.vaccine.2010.07.075","volume":"28","author":"LW Baillie","year":"2010","unstructured":"Baillie LW, Huwar TB, Moore S, Mellado-Sanchez G, Rodriguez L, Neeson BN et al (2010) An anthrax subunit vaccine candidate based on protective regions of Bacillus anthracis protective antigen and lethal factor. Vaccine 28(41):6740\u20136748","journal-title":"Vaccine"},{"issue":"19","key":"577_CR31","doi-asserted-by":"publisher","first-page":"8439","DOI":"10.1007\/s00253-016-7684-4","volume":"100","author":"N Suryanarayana","year":"2016","unstructured":"Suryanarayana N, Verma M, Thavachelvam K, Saxena N, Mankere B, Tuteja U et al (2016) Generation of a novel chimeric PALFn antigen of Bacillus anthracis and its immunological characterization in mouse model. Appl Microbiol Biotechnol 100(19):8439\u20138451","journal-title":"Appl Microbiol Biotechnol"},{"key":"577_CR32","first-page":"426","volume":"45","author":"A Varshney","year":"2016","unstructured":"Varshney A, Puranik N, Kumar M, Goel A (2016) Immunogenecity of a chimeric protein of Bacillus anthracis protective antigen and lethal factor in murine model. Int J Infect Dis 45:426","journal-title":"Int J Infect Dis"}],"container-title":["Medical Microbiology and Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00430-019-00577-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00430-019-00577-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00430-019-00577-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,21]],"date-time":"2020-01-21T20:18:27Z","timestamp":1579637907000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00430-019-00577-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,22]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["577"],"URL":"https:\/\/doi.org\/10.1007\/s00430-019-00577-x","relation":{},"ISSN":["0300-8584","1432-1831"],"issn-type":[{"value":"0300-8584","type":"print"},{"value":"1432-1831","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,22]]},"assertion":[{"value":"29 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}